SENESCENT MACROPHAGES PROMOTE KRAS-DRIVEN LUNG TUMORIGENESIS

被引：0
|
作者：
Prieto, L., I
Sturmlechner, I
Graves, S., I
Zhang, C.
Goplen, N. P.
Yi, E. S.
Haston, S.
Gonzalez-Gualda, E.
Morsli, S.
Ge, J.
Reen, V
Calderwood, A.
机构：
来源：
CANCER DISCOVERY | 2023年 / 13卷 / 08期
关键词：
D O I：
10.1158/2159-8290.CD-RW2023-092
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Senescent macrophages in the tumor microenvironment support lung tumor initiation and immunosuppression. ©2023 American Association for Cancer Research.
引用
收藏
页码：1758 / 1758
页数：1
相关论文
共 50 条
  • [31] The ERBB network facilitates KRAS-driven lung tumorigenesis (vol 10, pg eaao2565, 2018)
    Kruspig, B.
    Monteverde, T.
    Neidler, S.
    Hock, A.
    Kerr, E.
    Nixon, C.
    Clark, W.
    Hedley, A.
    Laing, S.
    Coffelt, S. B.
    Le Quesne, J.
    Dick, C.
    Vousden, K.
    Martins, C. P.
    Murphy, D. J.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (468)
  • [32] Syndecan-1 is required for oncogenic Kras-driven PDAC tumorigenesis and maintenance
    Yao, Wantong
    Wang, Wei
    Taguchi, Ayumu
    Kapoor, Avnish
    Momin, Amin
    Jiang, Hong
    Rose, Johnathon
    Celiktas, Muge
    Deem, Angela
    Hanash, Samir
    DePinho, Ronald
    Ying, Haoqiang
    Draetta, Giulio
    [J]. CANCER RESEARCH, 2015, 75
  • [33] Nrdc inhibits Kras-driven pancreatic tumorigenesis through suppressing spontaneous pancreatitis
    Ikuta, Kozo
    Fukuda, Akihisa
    Tsuda, Tomoyuki
    Maruno, Takahisa
    Kanda, Keitaro
    Nishi, Eiichirou
    Seno, Hiroshi
    [J]. CANCER SCIENCE, 2018, 109 : 514 - 514
  • [34] Loss of epithelial membrane protein 2 enhances Kras-driven lung tumorigenesis via FAK/AKT pathways
    Jang, Ji Yun
    Park, Mi Kyung
    Lee, Chang Hoon
    Lee, Ho
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [35] Opening a New GATAway for Treating KRAS-Driven Lung Tumors
    Barbacid, Mariano
    [J]. CANCER CELL, 2012, 21 (05) : 598 - 600
  • [36] Arf suppresses the growth and progression of Kras-driven lung tumors
    Busch, Stephanie E.
    Gurley, Kay E.
    Moser, Russell D.
    Kelly-Spratt, Karen S.
    Kemp, Christopher J.
    [J]. CANCER RESEARCH, 2011, 71
  • [37] Targeting platelets for improved outcome in KRAS-driven lung adenocarcinoma
    Stephanie R. Hyslop
    Marliese Alexander
    Alesha A. Thai
    Ariena Kersbergen
    Andrew J. Kueh
    Marco J. Herold
    Jason Corbin
    Pradnya Gangatirkar
    Ashley P. Ng
    Benjamin J. Solomon
    Warren S. Alexander
    Kate D. Sutherland
    Emma C. Josefsson
    [J]. Oncogene, 2020, 39 : 5177 - 5186
  • [38] Immunogenic chemotherapy effectively inhibits KRAS-Driven lung cancer
    Wang, Dong
    Cong, Jingjing
    Fu, Binqing
    Zheng, Xiaohu
    Sun, Rui
    Tian, Zhigang
    Wei, Haiming
    [J]. CANCER LETTERS, 2020, 492 : 31 - 43
  • [39] Extracellular RNA signatures of mutant KRAS-driven lung cancer
    Maroli, Sree Lakshmi Velandi
    Reggiardo, Roman E.
    Khojah, Reem
    Kim, Daniel H.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [40] iRhom2 regulates ERBB signalling to promote KRAS-driven tumour growth of lung cancer cells
    Sieber, Boris
    Lu, Fangfang
    Stribbling, Stephen M.
    Grieve, Adam G.
    Ryan, Anderson J.
    Freeman, Matthew
    [J]. JOURNAL OF CELL SCIENCE, 2022, 135 (17)
12345